TABLE 1.
Family and patient genderb (age [yr]) | PFGE type | spa type | MLSTc | SCCmec type | AGR type | Toxin profiled |
---|---|---|---|---|---|---|
1 | ||||||
M (36) | 50 | t437 | 59 | V | 1 | SEB |
F (31) | 50 | t437 | 59 | V | 1 | SEB |
FS (0) | 50 | t437 | 59 | V | 1 | SEB |
2 | ||||||
M (29) | 46 | t008 | 8 | IV | 1 | LukED |
MS (8) | 46 | t008 | 8 | IV | 1 | LukED |
3 | ||||||
F (28) | 297 | t441 | 59 | NTe | 1 | SEB |
FS (5) | 297 | t441 | 59 | NT | 1 | SEB |
FS (2) | 297 | t441 | 59 | NT | 1 | SEB |
4 | ||||||
M (57) | 218 | t008 | 8 | IV | 1 | LukED |
F (48) | 218 | t008 | 8 | IV | 1 | LukED |
5 | ||||||
M (42) | 206 | t008 | 8 | IV | 1 | LukED |
F (41) | 206 | t008 | 8 | IV | 1 | LukED |
6 | ||||||
M (40) | 50 | t437 | 59 | V | 1 | SEB |
MS (2) | 50 | t437 | 59 | V | 1 | SEB |
FS (0) | 50 | t437 | 59 | V | 1 | SEB |
7 | ||||||
M (68) | 28 | t131 | 80 | IV | 3 | ETD |
F (68) | 28 | t131 | 80 | IV | 3 | ETD |
8 | ||||||
M (39) | 218 | t008 | 8 | IV | 1 | LukED |
F (38) | 218 | t008 | 8 | IV | 1 | LukED |
FS (3) | 218 | t008 | 8 | IV | 1 | LukED |
9 | ||||||
M (37) | 373 | t313 | 30 | NT | 3 | —f |
F (36) | 373 | t313 | 30 | NT | 3 | — |
FS (0) | 373 | t313 | 30 | NT | 3 | — |
10 | ||||||
M (39) | 289 | t355 | 377 | V | 1 | — |
FS (8) | 289 | t355 | 377 | V | 1 | — |
FS (5) | 289 | t355 | 377 | V | 1 | — |
MS (0) | 289 | t355 | 377 | V | 1 | — |
All MRSA strains contained the mecA gene, the S. aureus fragment, and PVL genes and were negative for LukM.
M, male; F, female; S, sibling.
MLST, multilocus sequence type.
Only genes, encoding the different toxins, which were positive in the PCR are shown.
Only a mecA band detected.
—, no toxins detected.